1Mby1M Virtual Accelerator Investor Forum: With Darshana Zaveri of Catalyst Health Ventures (Part 4)

Sramana Mitra: Given that you are in a sector that is very relevant to what we are going through right now, what do you see is going to happen? There is a furious effort to come up with all kinds of testing devices with coronavirus and testing for antibodies of who has already gotten it.

Read Full Article »

1Mby1M Virtual Accelerator Investor Forum: With Darshana Zaveri of Catalyst Health Ventures (Part 3)

Sramana Mitra: What is the go-to market strategy for this company? What is your investment thesis around go-to market strategies? You mentioned early on that these companies don’t necessarily go to market on their own. Darshana Zaveri: This company did exit. It was bought out in 2018 by Boston Scientific. We did the seed round

Read Full Article »

1Mby1M Virtual Accelerator Investor Forum: With Darshana Zaveri of Catalyst Health Ventures (Part 2)

Sramana Mitra: What about geography? You’re based in the Boston area. Where do you like to invest? Darshana Zaveri: We’re pretty broad across the US. We’re a very small team ourselves. We’re two Managing Partners and a few folks in the back office. We tend to be New England focused just because of our location

Read Full Article »

1Mby1M Virtual Accelerator Investor Forum: With Darshana Zaveri of Catalyst Health Ventures (Part 1)

Responding to a popular request, we are now sharing transcripts of our investor podcast interviews in this new series. The following interview with Darshana Zaveri was recorded in April 2020. Darshana Zaveri, Managing Partner at Catalyst Health Ventures, discusses the firm’s medical device-focused investment thesis, including the nuances of epidemiologic diagnostics that are currently immensely

Read Full Article »

479th 1Mby1M Entrepreneurship Podcast With Darshana Zaveri, Catalyst Health Ventures

Darshana Zaveri, Managing Partner at Catalyst Health Ventures, discusses the firm’s medical device focused investment thesis, including the nuances of epidemiologic diagnostic that are currently immensely relevant. The Catalyst investment team also includes Managing Partner Josh Phillips and Principal Neil Swami.